Search Articles

View query in Help articles search

Search Results (1 to 10 of 1739 Results)

Download search results: CSV END BibTex RIS


Effectiveness and Cost-Effectiveness of Using a Social Robot in Residential Care for Individuals With Challenges in Daily Structure and Planning: Protocol for a Multiple-Baseline Single Case Trial and Health Economic Evaluation

Effectiveness and Cost-Effectiveness of Using a Social Robot in Residential Care for Individuals With Challenges in Daily Structure and Planning: Protocol for a Multiple-Baseline Single Case Trial and Health Economic Evaluation

With 24 participants, a significant intervention effect (P Primary outcome data will be analyzed using a multilevel model (R, version 4.0+; package lme4) to investigate whether there is a significant difference between the level of professional care support moments (frequency or duration) per week in the baseline phase and the effect phase. The dependent continuous variable is the frequency and duration of professional care support moments per week.

Kirstin N van Dam, Marieke F M Gielissen, Nienke M Siebelink, Ghislaine A P G van Mastrigt, Wouter den Hollander, Brigitte Boon

JMIR Res Protoc 2025;14:e67841

What Matters Most to Veterans When Deciding to Use Technology for Health: Cross-Sectional Analysis of a National Survey

What Matters Most to Veterans When Deciding to Use Technology for Health: Cross-Sectional Analysis of a National Survey

However, a greater proportion of veterans with (compared to without) prevalent mental health conditions reported the following considerations to be “very important”: seeing information about DHTs on social media (those with mental health conditions: 42/428, 9.8%; those without mental health conditions: 19/328, 5.8%; χ22=6.2; P=.05); having community support through Veteran Service Organizations, churches, libraries, or other organizations to use DHTs (with: 56/427, 13.1%; without: 25/327, 7.6%; χ22=7.9; P=.02

Bella Etingen, Bridget M Smith, Stephanie L Shimada, Stephanie A Robinson, Robin T Higashi, Ndindam Ndiwane, Kathleen L Frisbee, Jessica M Lipschitz, Eric Richardson, Dawn Irvin, Timothy P Hogan

JMIR Form Res 2025;9:e77113

Novel Virtual Reality Intervention for Stress Reduction Among Patients With or at Risk for Cardiovascular Disease: Mixed Methods Pilot Study

Novel Virtual Reality Intervention for Stress Reduction Among Patients With or at Risk for Cardiovascular Disease: Mixed Methods Pilot Study

The initial model demonstrated good fit and accounted for 86% of the variability in Δ-STAI-S (multiple R=0.96; adjusted R2=0.86; ANOVA of regression: P There was no significant change in systolic or diastolic BP among participants (Table 2). Pre- versus postexperience HR recordings demonstrated a statistically significant decreased mean HR of nearly 6 beats per minute.

Katherine E Makaroff, Christopher Van, Vincent Grospe, Lynae Edmunds, Marcella A Calfon-Press, Karol E Watson, Tamara Horwich

JMIR Cardio 2025;9:e66557

eHealth Literacy and Participation in Remote Blood Pressure Monitoring Among Patients With Hypertension: Cross-Sectional Study

eHealth Literacy and Participation in Remote Blood Pressure Monitoring Among Patients With Hypertension: Cross-Sectional Study

With 47.3% adult population with hypertension in the United States in 2021 [29], using 5% type 1 error (P=.05), the minimum sample size required to estimate participation in RBPM was 383 participants [30]. A minimum of 500 sample size has been recommended for detecting differences between the sample estimates and the population in observational studies involving logistic regression [31]. We stopped recruitment as soon as possible when we reached a sample size of 500.

Chinwe E Eze, Michael P Dorsch, Antoinette B Coe, Corey A Lester, Lorraine R Buis, Karen B Farris

J Med Internet Res 2025;27:e71926

Population-Based Digital Health Interventions to Deliver at-Home COVID-19 Testing: SCALE-UP II Randomized Clinical Trial

Population-Based Digital Health Interventions to Deliver at-Home COVID-19 Testing: SCALE-UP II Randomized Clinical Trial

Reach-Accept testing in the Chatbot arm was lower than in SMS text messaging (174/1051, 16.6% vs 555/1066, 52.1%; a RR 0.317, 98.33% CI 0.27‐0.38; P Reach-Accept testing was higher among participants messaged every 10 days vs every 30 days (860/15,717, 5.5% vs 752/15,722, 4.8%; a RR 1.144, 97.5% CI 1.03‐1.28; P=.01; Table 2), and lower if the participants were offered access to PN compared with those in the no PN condition (680/15,718, 4.3% vs 932/15,721, 5.9%; a RR 0.729, 97.5% CI 0.65‐0.81; P Out of 2117 participants

Guilherme Del Fiol, Tatyana V Kuzmenko, Brian Orleans, Jonathan J Chipman, Tom Greene, Ray Meads, Kimberly A Kaphingst, Bryan Gibson, Kensaku Kawamoto, Andy J King, Tracey Siaperas, Shlisa Hughes, Alan Pruhs, Courtney Pariera Dinkins, Cho Y Lam, Joni H Pierce, Ryzen Benson, Emerson P Borsato, Ryan C Cornia, Leticia Stevens, Richard L Bradshaw, Chelsey R Schlechter, David W Wetter

J Med Internet Res 2025;27:e74145